Efficacy of bronchial artery embolization for hemoptysis in patients with idiopathic bronchiectasis and related risk factors for re-currence
Objective To analyze the safety and efficacy of bronchial artery embolization(BAE)for treatment of hemoptysis in patients with idiopathic bronchiectasis and related risk factors of recurrence.Methods The clinical data of 108 idiopathic bronchiectasis patients with hemoptysis who underwent BAE treatment in Jinhua Central Hospital from January 2020 to March 2023 were retrospectively analyzed.Multivariate Cox regression analysis was used to investigate the risk factors related to the recurrence of hemoptysis after BAE.Results The technical success rate of BAE procedure was 100.0％,and a total of 403 responsible blood vessels were discovered.Among 108 patients 105 had instant termination of hemorrhage after BAE,with a hemostasis rate of 97.2％.During the median follow-up time of 13(8.0,24.8)months,recurrence of hemoptysis occurred in 40 patients with a recurrence rate of 37.0％.Multivariate Cox regression analysis revealed that non-first bleeding was an independent risk factor for recurrence of hemoptysis(HR=1.964,95％CI:1.018-3.792,P=0.044).Conclusion BAE is safe and effective for treatment of hemoptysis in patients with idiopathic bronchiectasis,and the non-first bleeding is a risk factor for the recurrence of hemoptysis after BAE.
万方数据
维普
